semaglutide weight loss clinic riverview Introducing our newest medical solution Tirzepatide for Medical Weight Loss

Athletic Recovery Exercise generates oxidative stress

Pharmaceutical companies are already racing to develop: next-generation GLP-1 drugs oral GLP-1 formulations dual- and triple-agonist metabolic therapies combination treatments targeting obesity and metabolic syndrome For sponsors, the commercial stakes are enormous

The effect of Wegovy 2.4 mg once weekly on the risk of major cardiovascular events such as death, heart attack, or stroke was studied in adults with known heart disease and either obesity or overweight compared with those on placebo (an inactive injection)

doi: 10.1136/rmdopen-2025-005776

doi:10.1007/s00394-018-1886-8 Gillies NA, Milan AM, Chia PHP, et al